Breaking News Instant updates and real-time market news.

NVS

Novartis

$86.34

3.78 (4.58%)

05:50
06/23/17
06/23
05:50
06/23/17
05:50

Novartis: half of eligible patients remain in TFR nearly 2 years after Tasigna

Novartis announced results from additional analyses of the ENESTfreedom and ENESTop clinical trials, which found that approximately half of adult patients with Philadelphia chromosome-positive, or Ph+, chronic myeloid leukemia, or CML, in the chronic phase, or CP, who discontinued Tasigna remain in Treatment-free Remission, or TFR, nearly two years after stopping treatment. The 96-week results from these two open-label Phase II trials, presented at the 22nd Congress of the European Hematology Association, or EHA, add to the growing body of evidence examining the ability to remain in TFR in patients who achieved a sustained deep molecular response, or DMR, with Tasigna and met additional eligibility criteria prior to discontinuing treatment. TFR is the ability to maintain molecular response, or MR, after stopping tyrosine kinase inhibitor, or TKI, therapy in patients with Ph+ CML-CP.

  • 26

    Jun

  • 12

    Jul

NVS Novartis
$86.34

3.78 (4.58%)

06/08/17
06/08/17
UPGRADE
Target $100

Buy
Kite Pharma upgraded to Buy on Axi-Cel manufacturing edge at BTIG
As previously reported, BTIG analyst Dane Leone upgraded Kite Pharma (KITE) to Buy from Neutral and set a $100 price target on the shares. Data from Novartis (NVS) and Juno (JUNO) have failed to deliver any recognizable differentiation, though Leone gives Kite "a clear win" for the manufacturing of Axi-Cel versus peers, he tells investors. The analyst sees Kite having the cleanest pathway to approval for diffuse large B-cell lymphoma and, given Kite's manufacturing edge, he estimates that Axi-Cel can take about 60% of share within the U.S. DLBCL market.
06/20/17
PIPR
06/20/17
NO CHANGE
Target $557
PIPR
Overweight
Piper says buy Regeneron on today's selloff, ups target to $557
Piper Jaffray analyst Edward Tenthoff recommends using today's weakness in shares of Regeneron Pharmaceuticals (REGN) after Novartis (NVS) reported positive Phase III data on brolucizumab as a buying opportunity. While brolucizumab is a competitive threat to Regeneron's Eylea, Novartis will not file until 2018 due to manufacturing issues, Tenthoff tells investors in a research note. He continues to expect Eylea sales growth of 6.1% to $3.52B this year and 5% to $3.7B in 2018 before brolucizumab hits the market in 2019. Tenthoff raised his price target for Regeneron Pharmaceuticals to $557 from $446 to reflect a higher price-to-earnings multiple and reiterates an Overweight rating on the shares. Positive Dupixent Phase III asthma data this fall would dramatically expand the company's market opportunity, he contends.
06/22/17
RAJA
06/22/17
NO CHANGE
RAJA
Regeneron price target raised to $547 from $475 at Raymond James
Raymond James analyst Christopher Raymond increased his price target on Regeneron (REGN) after meeting with the company's management. After Novartis (NVS) released data on a potential competitor to Regeneron's Eylea, Raymond thinks that Novartis' drug will not be launched for at least two more years. The analyst adds that the launch of Regeneron's Duipxent drug is going well, while the company is confident that upcoming data will show that the drug effectively treats asthma. He remains upbeat on the company's outlook and thinks that the stock can continue to rise. Raymond keeps an Outperform rating on the stock.
06/22/17
LEHM
06/22/17
UPGRADE
LEHM
Equal Weight
Novartis upgraded to Equal Weight from Underweight at Barclays

TODAY'S FREE FLY STORIES

DE

Deere

$123.98

-2.65 (-2.09%)

, EL

Estee Lauder

$98.32

-2.75 (-2.72%)

20:25
08/17/17
08/17
20:25
08/17/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DE

Deere

$123.98

-2.65 (-2.09%)

EL

Estee Lauder

$98.32

-2.75 (-2.72%)

FL

Foot Locker

$47.70

-0.87 (-1.79%)

HIBB

Hibbett Sports

$11.50

-0.3 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 18

    Aug

  • 18

    Aug

  • 18

    Aug

  • 22

    Nov

PCTY

Paylocity

$45.10

-1.06 (-2.30%)

, PAYX

Paychex

$54.98

-1.26 (-2.24%)

18:11
08/17/17
08/17
18:11
08/17/17
18:11
Hot Stocks
Paylocity announces Michael Haske's promotion to president & COO »

Paylocity announced that…

PCTY

Paylocity

$45.10

-1.06 (-2.30%)

PAYX

Paychex

$54.98

-1.26 (-2.24%)

ADP

ADP

$104.68

-6.42 (-5.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

  • 12

    Sep

  • 30

    Oct

  • 17

    Aug

SN

Sanchez Energy

$4.87

-0.145 (-2.89%)

18:04
08/17/17
08/17
18:04
08/17/17
18:04
Hot Stocks
Sanchez Energy to sell Javelina asset in Eagle Ford shale for about $105M »

Sanchez Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 16

    May

BABA

Alibaba

$163.92

4.42 (2.77%)

17:50
08/17/17
08/17
17:50
08/17/17
17:50
Recommendations
Alibaba analyst commentary at Baird »

Alibaba price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

ASYS

Amtech Systems

$10.14

-0.51 (-4.79%)

17:48
08/17/17
08/17
17:48
08/17/17
17:48
Syndicate
Amtech Systems announces common stock offering, no amount given »

Amtech Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPCAY

Cathay Pacific

$7.47

0.15 (2.05%)

17:47
08/17/17
08/17
17:47
08/17/17
17:47
Upgrade
Cathay Pacific rating change at Goldman Sachs »

Cathay Pacific upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$177.25

-0.83 (-0.47%)

17:32
08/17/17
08/17
17:32
08/17/17
17:32
Hot Stocks
Raytheon awarded $104.8M government contract »

Raytheon Missile Systems,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWH

Sportsman's Warehouse

$3.46

-0.12 (-3.35%)

, GLOB

Globant

$42.26

-0.64 (-1.49%)

17:32
08/17/17
08/17
17:32
08/17/17
17:32
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SPWH

Sportsman's Warehouse

$3.46

-0.12 (-3.35%)

GLOB

Globant

$42.26

-0.64 (-1.49%)

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

GPS

Gap

$22.68

0.11 (0.49%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

FLDM

Fluidigm

$3.60

-0.04 (-1.10%)

SENS

Senseonics

$2.44

0.02 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 21

    Aug

  • 23

    Aug

  • 18

    Aug

LMT

Lockheed Martin

$301.42

-4.38 (-1.43%)

17:32
08/17/17
08/17
17:32
08/17/17
17:32
Hot Stocks
Lockheed Martin, others awarded $499M government contract »

Lockheed Martin, Fort…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

CTRL

Control4

$22.27

-0.9 (-3.88%)

, AMRI

Albany Molecular

$21.74

-0.01 (-0.05%)

17:21
08/17/17
08/17
17:21
08/17/17
17:21
Hot Stocks
Control4 to replace Albany Molecular in S&P 600 at open on 8/22 »

The Carlyle Group (CG)…

CTRL

Control4

$22.27

-0.9 (-3.88%)

AMRI

Albany Molecular

$21.74

-0.01 (-0.05%)

CG

Carlyle Group

$21.20

-0.2 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

CI

Cigna

$178.03

-1.83 (-1.02%)

17:15
08/17/17
08/17
17:15
08/17/17
17:15
Hot Stocks
Cigna's Bacus sells 2,236 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

17:09
08/17/17
08/17
17:09
08/17/17
17:09
General news
Sen. Corker: Trump has not demonstrated competence to be president »

According to various…

BTU

Peabody Energy

$27.94

-0.27 (-0.96%)

17:07
08/17/17
08/17
17:07
08/17/17
17:07
Syndicate
Peabody Energy files to sell 12.8M shares of common stock for holders »

Peabody Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEMI

Chembio Diagnostics

$6.05

-0.1 (-1.63%)

17:02
08/17/17
08/17
17:02
08/17/17
17:02
Hot Stocks
Chembio Diagnostics CFO Richard Larkin to retire »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMT

America's Car-Mart

$36.90

-0.65 (-1.73%)

17:01
08/17/17
08/17
17:01
08/17/17
17:01
Earnings
America's Car-Mart reports Q1 EPS 90c, consensus 91c »

Reports Q1 revenue $146M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$35.00

-0.75 (-2.10%)

16:59
08/17/17
08/17
16:59
08/17/17
16:59
Hot Stocks
General Motors' Jacoby sells 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$9.78

-0.19 (-1.91%)

, FLR

Fluor

$37.77

-0.67 (-1.74%)

16:59
08/17/17
08/17
16:59
08/17/17
16:59
Hot Stocks
President Donald Trump shelves plans to create infrastructure advisory council »

According to various…

CBI

CB&I

$9.78

-0.19 (-1.91%)

FLR

Fluor

$37.77

-0.67 (-1.74%)

ACM

Aecom

$31.09

-0.43 (-1.36%)

MTZ

MasTec

$39.20

0.45 (1.16%)

CCI

Crown Castle

$104.14

0.35 (0.34%)

JEC

Jacobs Engineering

$50.25

-0.8 (-1.57%)

MLM

Martin Marietta

$200.41

-4.7 (-2.29%)

USCR

U.S. Concrete

$77.20

-0.9 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

CQP

Cheniere Energy Partners

$28.08

-0.08 (-0.28%)

16:53
08/17/17
08/17
16:53
08/17/17
16:53
Syndicate
Breaking Syndicate news story on Cheniere Energy Partners »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDS

Dillard's

$54.83

-1.1 (-1.97%)

16:50
08/17/17
08/17
16:50
08/17/17
16:50
Hot Stocks
Dillard's raises quarterly dividend to 10c from 7c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABTL

Autobytel

$8.30

-0.12 (-1.43%)

16:46
08/17/17
08/17
16:46
08/17/17
16:46
Hot Stocks
Autobytel announces purchases under stock repurchase authorization »

Autobytel announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBL

GAMCO Investors

$29.41

-0.4 (-1.34%)

, CMT

Core Molding

$21.07

-0.36 (-1.68%)

16:43
08/17/17
08/17
16:43
08/17/17
16:43
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, Core Molding »

Gabelli reports 10.94%…

GBL

GAMCO Investors

$29.41

-0.4 (-1.34%)

CMT

Core Molding

$21.07

-0.36 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

GUID

Guidance Software

16:41
08/17/17
08/17
16:41
08/17/17
16:41
Hot Stocks
Breaking Hot Stocks news story on Guidance Software »

Soros Fund Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBL

GAMCO Investors

$29.41

-0.4 (-1.34%)

, MTRN

Materion

$37.00

-1.1 (-2.89%)

16:41
08/17/17
08/17
16:41
08/17/17
16:41
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, Materion »

Gabelli reports 6.66%…

GBL

GAMCO Investors

$29.41

-0.4 (-1.34%)

MTRN

Materion

$37.00

-1.1 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 14

    Nov

FALC

FalconStor

$0.19

-0.004 (-2.12%)

16:41
08/17/17
08/17
16:41
08/17/17
16:41
Hot Stocks
FalconStor announces Todd Brooks as CEO and Patrick McClain as CFO »

FalconStor announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:36
08/17/17
08/17
16:36
08/17/17
16:36
General news
Fed Balance Sheet Level data reported »

Week of 8/16 Fed Balance…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.